Open access · CC-BY
via OpenAlex
Senescence-Associated Secretory Phenotype (SASP) in Diabetes
Journal of Pharma Insights and Research. · 2025 · ▲ 2 citations
Abstract
Cellular senescence(definition) represents a critical biological process characterized by permanent cell cycle arrest and distinct metabolic alterations. The senescence-associated secretory phenotype (SASP) has emerged as a fundamental mediator linking cellular aging to various pathological conditions, including diabetes mellitus. Recent investigations have unveiled the intricate relationship between SASP and pancreatic β-cell dysfunction, insulin resistance, and diabetic complications. The accumulation of senescent cells in pancreatic islets correlates with diminished insulin production and secretion, while SASP factors contribute to chronic inflammation and oxidative stress. The molecular mechanisms underlying SASP in diabetes involve complex interactions between p16INK4a/p53 pathways, DNA damage responses, and inflammatory mediators. Notably, senescent β-cells exhibit altered expression of key metabolic regulators and increased production of pro-inflammatory cytokines, chemokines, and matrix-degrading proteins. The identification of these pathways has led to innovative therapeutic strategies, including senolytic drugs that selectively eliminate senescent cells. Preclinical studies demonstrate that targeting SASP can improve glucose homeostasis, enhance insulin sensitivity, and potentially reverse diabetic complications. Moreover, the interaction between SASP and metabolic dysfunction extends beyond pancreatic tissue, affecting adipose tissue, skeletal muscle, and liver function
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.69613/qjzz6g14
- Canonical
- link ↗
- Fetched
- 2026-10-05 MST
Cite this
APA
Mode, N., & Chaitanya, B. (2025). Senescence-Associated Secretory Phenotype (SASP) in Diabetes. <em>Journal of Pharma Insights and Research.</em>. https://doi.org/10.69613/qjzz6g14
Vancouver
Mode N, Chaitanya B. Senescence-Associated Secretory Phenotype (SASP) in Diabetes. Journal of Pharma Insights and Research.. 2025. doi:10.69613/qjzz6g14.
BibTeX
@article{nandini2025Senesc,
title = {Senescence-Associated Secretory Phenotype (SASP) in Diabetes},
author = {Nandini Mode and B Chaitanya},
journal = {Journal of Pharma Insights and Research.},
year = {2025},
doi = {10.69613/qjzz6g14},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preprints.org 2025
Preprint · CC-BY
Metabolically Active but Dysfunctional: The Role of Senescence and SASP in Metabolic Diseases
Aging and Disease 2021
Open access · CC-BY
Cellular Senescence Affects Cardiac Regeneration and Repair in Ischemic Heart Disease
Endocrinology 2021
Open access · OA
Role of Cellular Senescence in Type II Diabetes
Drug design, development and therapy 2025
Open access · OA
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.
Diabetes 2015
Preprint · OA
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Frontiers in Endocrinology 2026
Open access · CC-BY